Year archive

CStone Pharmaceuticals — 2025 filings

All 190 regulatory filings released by CStone Pharmaceuticals (2616) in 2025, sourced directly from the official regulator.

190 Filings

2025 Period

2025 filings (190)

Filing	Released	Lang
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2025 FOURTH TRANCHE OF SCI-TECH INNOVATION BONDS Capital/Financing Update	2025-12-10	English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES THE INCLUSION OF GAVRETO (PRALSETINIB) IN THE 2025 NATIONAL REIMBURSEMENT DRUG LIST Regulatory Filings	2025-12-08	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2025 Regulatory Filings	2025-12-04	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-12-02	English
Monthly Return Regulatory Filings	2025-12-02	English
CONNECTED TRANSACTION ACQUISITION OF 100% EQUITY INTEREST IN HIGH-END SUPPORT M&A Activity	2025-11-27	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-11-27	English
VOLUNTARY ANNOUNCEMENT - EUROPEAN COMMISSION APPROVED SUGMALIMAB FOR STAGE III NON-SMALL CELL LUNG CANCER Regulatory Filings	2025-11-25	English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2025 THIRD TRANCHE OF SCI-TECH INNOVATION BONDS Capital/Financing Update	2025-11-17	English
VOLUNTARY ANNOUNCEMENT - ACAAI 2025 \| CS2015 (OX40L/TSLP BISPECIFIC ANTIBODY) MAKES INTERNATIONAL DEBUT Regulatory Filings	2025-11-07	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2025 Regulatory Filings	2025-11-06	English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES NMPA APPROVAL OF IND FOR THE PHASE II CLINICAL TRIALS OF CS2009 (PD-1/VEGF/CTLA-4 TRI-SPECIFIC ANTIBODY) COMBINATION THERAPIES, FURTHER EXPLORING IT Regulatory Filings	2025-11-04	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-11-03	English
Monthly Return Regulatory Filings	2025-11-03	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Board/Management Information	2025-11-03	English
(1) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (2) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (3) CHANGE IN COMPOSITION OF BOARD COMMITTEES Board/Management Information	2025-11-03	English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2025 SECOND TRANCHE OF SCI-TECH INNOVATION BONDS Capital/Financing Update	2025-10-30	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-10-30	English
RESULTS REPORT FOR THE THIRD QUARTER OF 2025 Interim / Quarterly Report Q3 2025	2025-10-30	English
OVERSEAS REGULATORY ANNOUNCEMENT NOTICE OF RESULTS PRESENTATION FOR THE THIRD QUARTER OF 2025 Investor Presentation	2025-10-28	English
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG AND SENIOR MANAGEMENT BY 1,000,000 SHARES Director's Dealing	2025-10-23	English
ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE THIRD QUARTER OF 2025 Regulatory Filings	2025-10-20	English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE THIRD QUARTER OF 2025 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED Regulatory Filings	2025-10-20	English
VOLUNTARY ANNOUNCEMENT - ESMO 2025: CSTONE DISCLOSES PHASE I DATA FOR CS2009 (PD-1/VEGF/CTLA-4 TRISPECIFIC ANTIBODY) Regulatory Filings	2025-10-20	English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES CHMP POSITIVE OPINION FOR SUGEMALIMAB, EXPANDING ITS POTENTIAL USE TO COVER BOTH STAGE III AND IV NSCLC IN EUROPE Regulatory Filings	2025-10-17	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-10-16	English
VOLUNTARY ANNOUNCEMENT - ESMO 2025 PREVIEW: CSTONE TO PRESENT PHASE I DOSE-ESCALATION DATA FOR PD-1/VEGF/CTLA-4 TRISPECIFIC ANTIBODY AND TRIAL-IN-PROGRESS UPDATE FOR ROR1 ADC Regulatory Filings	2025-10-13	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-10-09	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025 Share Issue/Capital Change	2025-10-08	English
Monthly Return Regulatory Filings	2025-10-08	English
INTERIM REPORT 2025 Interim / Quarterly Report H1 2025	2025-09-29	English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES FIRST PATIENT ENROLLMENT IN GLOBAL PHASE II TRIAL OF CS2009 (PD-1/VEGF/CTLA-4 TRISPECIFIC ANTIBODY) IN AUSTRALIA Regulatory Filings	2025-09-23	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Governance Information	2025-09-23	English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR Board/Management Information	2025-09-23	English
INSIDE INFORMATION PROPOSED SPIN-OFF OF KASONG SCIENCE AND TECHNOLOGY AND QUOTATION OF ITS SHARES ON NATIONAL EQUITIES EXCHANGE AND QUOTATIONS Regulatory Filings	2025-09-22	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-09-16	English
ANNOUNCEMENT ON THE TERMINATION OF MERGER AND ACQUISITION OF HIGHFIELD RESOURCES LIMITED M&A Activity	2025-09-15	English
VOLUNTARY ANNOUNCEMENT - CSTONE TO SHOWCASE CS2015 (OX40L/TSLP BISPECIFIC ANTIBODY) AT ACAAI 2025 Regulatory Filings	2025-09-15	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-09-05	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-09-05	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025 Regulatory Filings	2025-09-04	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-09-03	English
Monthly Return Regulatory Filings	2025-09-02	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-08-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-08-29	English
OVERSEAS REGULATORY ANNOUNCEMENT ANNOUNCEMENT TO CREDITORS Transaction in Own Shares	2025-08-29	English
INSIDE INFORMATION ANNOUNCEMENT ON THE PLANS FOR THE REPURCHASE OF SHARES BY WAY OF CENTRALISED PRICE BIDDING Transaction in Own Shares	2025-08-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-08-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-08-29	English
CONNECTED TRANSACTION ACQUISITION OF 70% EQUITY INTEREST IN POWER SALES BY WAY OF CAPITAL INCREASE M&A Activity	2025-08-29	English
Interim dividend for the six months ended 30 June 2025 Notice of Dividend Amount	2025-08-29	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 Earnings Release H1 2025	2025-08-29	English
INTERIM REPORT 2025 Regulatory Filings	2025-08-29	English
GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS Share Issue/Capital Change	2025-08-27	English
OVERSEAS REGULATORY ANNOUNCEMENT NOTICE OF 2025 INTERIM RESULTS PRESENTATION Regulatory Filings	2025-08-26	English
PUBLICATION OF THE 2025 INTERIM RESULTS OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED Report Publication Announcement	2025-08-19	English
UPDATE ON MERGER AND ACQUISITION OF HIGHFIELD RESOURCES LIMITED M&A Activity	2025-08-18	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-08-15	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H2 2025	2025-08-14	English
INSIDE INFORMATION PROFIT ALERT ANNOUNCEMENT FOR THE FIRST HALF OF 2025 Earnings Release H1 2025	2025-08-13	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2025 Share Issue/Capital Change	2025-08-06	English
Monthly Return Regulatory Filings	2025-08-04	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-04	English
VOLUNTARY ANNOUNCEMENT - ESMO 2025: CSTONE TO DEBUT CS2009 CLINICAL DATA AND CS5001 TRIAL DESIGN Regulatory Filings	2025-07-28	English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2025 FIRST TRANCHE OF SUPER-SHORT-TERM BONDS Capital/Financing Update	2025-07-25	English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE SECOND QUARTER OF 2025 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED Regulatory Filings	2025-07-17	English
ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE SECOND QUARTER OF 2025 Regulatory Filings	2025-07-17	English
NEXT DAY DISCLOSURE RETURN Share Issue/Capital Change	2025-07-16	English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-07-16	English
ANNOUNCEMENT ON THE COMPLETION OF DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF EQUITY INTEREST IN XIBEI MINING AND CAPITAL INCREASE IN XIBEI MINING M&A Activity	2025-07-11	English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES NMPA APPROVAL FOR LOCALIZED MANUFACTURING OF GAVRETO (PRALSETINIB) IN CHINA Regulatory Filings	2025-07-10	English
PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-07-09	English
VOLUNTARY ANNOUNCEMENT - CSTONE SIGNS EXCLUSIVE LICENSE AGREEMENT WITH ISTITUTO GENTILI FOR SUGEMALIMAB IN WESTERN EUROPE AND THE UK Regulatory Filings	2025-07-08	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2025 Share Issue/Capital Change	2025-07-07	English
VOLUNTARY ANNOUNCEMENT - CLINICAL PROGRESS UPDATE ON CS2009 (PD-1/VEGF/CTLA-4 TRISPECIFIC ANTIBODY) Regulatory Filings	2025-07-07	English
VOLUNTARY ANNOUNCEMENT - LATEST UPDATE ON GLOBAL MULTICENTER PHASE III STUDY OF NOFAZINLIMAB IN HEPATOCELLULAR CARCINOMA Regulatory Filings	2025-07-04	English
Monthly Return Regulatory Filings	2025-07-03	English
VOLUNTARY ANNOUNCEMENT - CSTONE UNVEILS TWO BISPECIFIC ANTIBODY TARGETS FOR AUTOIMMUNE/INFLAMMATORY DISEASES Regulatory Filings	2025-07-03	English
TERMS OF REFERENCE OF THE NOMINATION COMMITTEE Governance Information	2025-06-25	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Governance Information	2025-06-25	English
(1) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 25, 2025; (2) RETIREMENT AND RESIGNATION OF DIRECTORS; AND (3) CHANGE IN COMPOSITION OF BOARD COMMITTEES Declaration of Voting Results & Voting Rights Announcements	2025-06-25	English
VOLUNTARY ANNOUNCEMENT - LONG-TERM SURVIVAL DATA OF GEMSTONE-302 TRIAL ON SUGEMALIMAB PUBLISHED IN THE LANCET ONCOLOGY Regulatory Filings	2025-06-19	English
ANNOUNCEMENT MADE PURSUANT TO RULES 13.51B(2) AND 13.51(2) OF THE LISTING RULES Regulatory Filings	2025-06-13	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-06-09	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2025 Regulatory Filings	2025-06-05	English
Monthly Return Regulatory Filings	2025-06-04	English
PROPOSALS FOR GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-06-03	English
FORM OF PROXY FOR ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-06-03	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-06-03	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-30	English
The Detailed Working Rules for the Sustainable Development Committee of the Board of Directors of Yankuang Energy Group Company Limited Governance Information	2025-05-30	English
The Detailed Working Rules for the Strategy and Development Committee of the Board of Directors of Yankuang Energy Group Company Limited Governance Information	2025-05-30	English
The Detailed Working Rules for the Remuneration Committee of the Board of Directors of Yankuang Energy Group Company Limited Governance Information	2025-05-30	English
The Detailed Working Rules for the Nomination Committee of the Board of Directors of Yankuang Energy Group Company Limited Governance Information	2025-05-30	English
The Detailed Working Rules for the Audit Committee of the Board of Directors of Yankuang Energy Group Company Limited Governance Information	2025-05-30	English
Rules of Procedures for the Board of Directors of Yankuang Energy Group Company Limited Governance Information	2025-05-30	English
Rules of Procedures for Shareholders' Meeting of Yankuang Energy Group Company Limited Governance Information	2025-05-30	English
ARTICLES OF ASSOCIATION OF YANKUANG ENERGY GROUP COMPANY LIMITED Governance Information	2025-05-30	English
(Update) Final Dividend for the Year Ended 31 December 2024 Notice of Dividend Amount	2025-05-30	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Governance Information	2025-05-30	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-30	English
CONNECTED TRANSACTION PROVISION OF FINANCIAL ASSISTANCE Capital/Financing Update	2025-05-30	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-30	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-30	English
ANNOUNCEMENT THE RESOLUTIONS PASSED AT THE 2024 ANNUAL GENERAL MEETING;DISTRIBUTION OF FINAL DIVIDEND;RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND ADJUSTMENT TO THE COMPOSITIO Declaration of Voting Results & Voting Rights Announcements	2025-05-30	English
ANNOUNCEMENT ON PARTICIPATION IN THE 2024 ANNUAL COLLECTIVE RESULTS PRESENTATION FOR THE SHANGHAI STOCK EXCHANGE MAIN BOARD HIGH DIVIDEND AND STRONG RETURNS THEME Regulatory Filings	2025-05-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-22	English
DOCUMENTS ON DISPLAY M&A Activity	2025-05-15	English
Revised Form of Proxy (the "New Form of Proxy") for Use at the Annual General Meeting for the Year Ended 31 December 2024 to be held on Friday, 30 May 2025 Proxy Solicitation & Information Statement	2025-05-15	English
Circular Proxy Solicitation & Information Statement	2025-05-15	English
SUPPLEMENTAL NOTICE OF 2024 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-05-15	English
ANNOUNCEMENT ON THE PARTICIPATION IN 2025 ONLINE COLLECTIVE RECEPTION ACTIVITY FOR INVESTORS Regulatory Filings	2025-05-13	English
PROGRESS ANNOUNCEMENT ON MERGER AND ACQUISITION OF HIGHFIELD RESOURCES LIMITED M&A Activity	2025-05-12	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-05-12	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2025 Regulatory Filings	2025-05-08	English
Monthly Return Regulatory Filings	2025-05-06	English
VOLUNTARY ANNOUNCEMENT - CSTONE PRESENTED FIVE LATEST STUDIES AT 2025 AACR ANNUAL MEETING Regulatory Filings	2025-05-06	English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2025 FIRST TRANCHE OF MEDIUM-TERM NOTES Capital/Financing Update	2025-04-30	English
Next Day Disclosure Return Transaction in Own Shares	2025-04-29	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-29	English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2024 Environmental & Social Information	2025-04-28	English
2024 ANNUAL REPORT Annual Report FY 2024	2025-04-28	English
(Update) Final Dividend for the Year Ended 31 December 2024 Notice of Dividend Amount	2025-04-28	English
Form of Proxy for Use at the Annual General Meeting for the Year Ended 31 December 2024 to be held on Friday, 30 May 2025 Proxy Solicitation & Information Statement	2025-04-28	English
Circular Proxy Solicitation & Information Statement	2025-04-28	English
NOTICE OF 2024 ANNUAL GENERAL MEETING AGM Information	2025-04-28	English
RESULTS REPORT FOR THE FIRST QUARTER OF 2025 Interim / Quarterly Report Q1 2025	2025-04-25	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-25	English
PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR Board/Management Information	2025-04-25	English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RELEVANT RULES OF PROCEDURE Governance Information	2025-04-25	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-25	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-25	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-24	English
NOTICE OF RESULTS PRESENTATION FOR THE FIRST QUARTER OF 2025 Regulatory Filings	2025-04-23	English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE FIRST QUARTER OF 2025 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED Regulatory Filings	2025-04-17	English
ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE FIRST QUARTER OF 2025 Regulatory Filings	2025-04-17	English
(I) GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO RSU SCHEME; AND (II) GRANT OF SHARE OPTIONS UNDER THE POST-IPO ESOP Share Issue/Capital Change	2025-04-11	English
NEXT DAY DISCLOSURE RETURN Share Issue/Capital Change	2025-04-10	English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-04-10	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-04-10	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-09	English
VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 560,000 SHARES, WITH ACCUMULATED PURCHASE TOTALLING 10,359,000 SHARES Director's Dealing	2025-04-09	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-08	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-08	English
DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF EQUITY INTEREST IN XIBEI MINING AND CAPITAL INCREASE IN XIBEI MINING; AND CONTINUING CONNECTED TRANSACTIONS M&A Activity	2025-04-08	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-04-08	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2025 Regulatory Filings	2025-04-07	English
PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-04-02	English
Monthly Return Share Issue/Capital Change	2025-04-01	English
2024 Environmental,Social and Governance Report Regulatory Filings	2025-03-28	English
Final Dividend for the Year Ended 31 December 2024 Notice of Dividend Amount	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
CONTINUING CONNECTED TRANSACTION Regulatory Filings	2025-03-28	English
CONNECTED TRANSACTION NON-PLANNING EXPENSES ARRANGEMENT AGREEMENTS FOR THREE SUBSIDIARIES Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
CONNECTED TRANSACTION NON-PLANNING EXPENSES ARRANGEMENT AGREEMENTS FOR THREE SUBSIDIARIES Regulatory Filings	2025-03-28	English
Provision of Financing Guarantee to the Companys Subsidiaries and Granting of Authorization to Yancoal Australia and Its Subsidiaries to Provide Guarantee for the Daily Operation of the Subsidiaries o Proxy Solicitation & Information Statement	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-28	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024; AND INSIDE INFORMATION ON CHANGE IN ACCOUNTING POLICY Regulatory Filings	2025-03-28	English
Annual Report 2024 Regulatory Filings	2025-03-28	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 Earnings Release FY 2024	2025-03-27	English
VOLUNTARY ANNOUNCEMENT - CSTONE TO SHOWCASE FIVE LATEST RESEARCH ACHIEVEMENTS AT AACR 2025 Regulatory Filings	2025-03-26	English
NOTICE OF 2024 ANNUAL RESULTS PRESENTATION Report Publication Announcement	2025-03-25	English
VOLUNTARY ANNOUNCEMENT - CSTONE SUBMITS APPLICATION TO THE EUROPEAN MEDICINES AGENCY FOR NEW INDICATION OF SUGEMALIMAB IN STAGE III NON-SMALL CELL LUNG CANCER Regulatory Filings	2025-03-24	English
DATE OF BOARD MEETING Report Publication Announcement	2025-03-17	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-03-13	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025 Regulatory Filings	2025-03-06	English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES SUBMISSION OF CLINICAL TRIAL APPLICATION IN AUSTRALIA FOR CS5001 (ROR1 ADC) IN COMBINATION WITH FIRST-LINE STANDARD-OF-CARE FOR DLBCL Regulatory Filings	2025-03-06	English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES FIRST PATIENT DOSED IN GLOBAL MULTICENTER PHASE I CLINICAL TRIAL OF CS2009, A PD-1/VEGF/CTLA-4 TRISPECIFIC ANTIBODY Regulatory Filings	2025-03-04	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-03-03	English
Monthly Return Regulatory Filings	2025-03-03	English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES PUBLICATION OF GEMSTONE-303 STUDY RESULTS FOR SUGEMALIMAB (CEJEMLY) IN JAMA Regulatory Filings	2025-02-25	English
PROPOSED APPOINTMENT OF NON-INDEPENDENT DIRECTOR Board/Management Information	2025-02-24	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-02-24	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-02-24	English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section Regulatory Filings	2025-02-24	English
PUBLICATION OF THE 2024 ANNUAL RESULTS OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED Report Publication Announcement	2025-02-20	English
CONNECTED TRANSACTION IN RELATION TO THE DEEMED DISPOSAL OF 47.168% EQUITY INTERESTS IN DONGFANG ELECTRICAL Share Issue/Capital Change	2025-02-14	English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES INCLUSION OF SUGEMALIMAB (CEJEMLY) AS FIRST-LINE COMBINATION THERAPY FOR NSCLC IN ESMO GUIDELINE Regulatory Filings	2025-02-10	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025 Share Issue/Capital Change	2025-02-06	English
Monthly Return Regulatory Filings	2025-02-06	English
VOLUNTARY ANNOUNCEMENT - CSTONE AND STEINCARES ENTER INTO STRATEGIC PARTNERSHIP TO MARKET SUGEMALIMAB IN LATIN AMERICA Regulatory Filings	2025-01-27	English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE FOURTH QUARTER OF 2024 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED Earnings Release Q4 2024	2025-01-20	English
ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE FOURTH QUARTER OF 2024 Regulatory Filings	2025-01-20	English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024 Regulatory Filings	2025-01-07	English
Monthly Return Regulatory Filings	2025-01-02	English

Filings by year

2026 31 filings
2025 190 filings
2024 214 filings
2023 236 filings
2022 406 filings
2021 228 filings
2020 260 filings
2019 236 filings
2018 201 filings
2017 199 filings
2016 173 filings
2015 126 filings
2014 133 filings
2013 95 filings
2012 99 filings
2011 87 filings
2010 81 filings
2009 93 filings
2008 68 filings
2007 33 filings
2006 50 filings
2005 43 filings
2004 22 filings
2003 19 filings
2002 14 filings
2001 18 filings
2000 11 filings
1999 6 filings